Department of Radiology, The Royal London Hospital, Barts Health NHS Trust, London, UK.
Radiology Department, King's College Hospital, Denmark Hill, London, UK.
J Ultrasound. 2022 Jun;25(2):339-342. doi: 10.1007/s40477-020-00535-x. Epub 2020 Nov 7.
We describe a case of a cholecystoduodenal fistula (CDF) diagnosed using oral contrast-enhanced ultrasound (CEUS). CDF is a rare type of biliary-enteric fistulation in which an abnormal communication forms between the gallbladder and duodenum. CDF are usually found in older patients, in the context of chronic cholecystitis, and can be associated with serious consequences. Given the non-specific presentation and limitations of the various imaging modalities, CDF are notoriously difficult to diagnose. CEUS is a recognised technique predominantly deployed for imaging following intravenous administration. Experience of CEUS has expanded into endocavitary use, including in the biliary and gastrointestinal systems. We describe a case of a CDF identified on intracavitary CEUS. This case report demonstrates oral ingestion of a diluted ultrasound contrast agent is a novel and safe mode of administration with stability of the contrast agent and the ability to define fistulation.
我们描述了一例经口服造影增强超声(CEUS)诊断的胆囊十二指肠瘘(CDF)。CDF 是一种罕见的胆肠瘘类型,在这种类型中,胆囊和十二指肠之间形成异常的沟通。CDF 通常发生在老年患者中,与慢性胆囊炎有关,并可能导致严重后果。鉴于各种影像学检查方式的非特异性表现和局限性,CDF 很难诊断。CEUS 是一种公认的技术,主要用于静脉内给药后的成像。CEUS 的经验已扩展到腔内使用,包括在胆道和胃肠道系统中。我们描述了一例经腔内 CEUS 诊断的 CDF。本病例报告证明,口服摄入稀释的超声造影剂是一种新颖且安全的给药方式,造影剂稳定,能够明确瘘管。